Название продукции:2,2,2-trifluoro-1-(piperidin-4-yl)ethanone oxalate

IUPAC Name:bis(2,2,2-trifluoro-1-(piperidin-4-yl)ethan-1-one); oxalic acid

CAS:1182349-50-3
Молекулярная формула:C16H22F6N2O6
Чистота:95%+
Номер в каталоге:CM363312
Молекулярная масса:452.35

Упаковочная единица Доступно для заказа Цена ($) Количество
CM363312-25mg in stock Žţ
CM363312-100mg in stock ǭŽij
CM363312-250mg in stock ƏǟƏ
CM363312-1g 1-2 Weeks řŽŁ
CM363312-5g 1-2 Weeks ǭŽijĜ
CM363312-10g 1-2 Weeks ƏǟǭŽ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1182349-50-3
Молекулярная формула:C16H22F6N2O6
Точка плавления:-
Smiles-код:OC(=O)C(O)=O.FC(F)(F)C(=O)C1CCNCC1.FC(F)(F)C(=O)C1CCNCC1
Плотность:
Номер в каталоге:CM363312
Молекулярная масса:452.35
Точка кипения:
Номер Mdl:MFCD11501649
Хранение:

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Fluorinated Compounds
Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.